サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386329

生殖補助医療の世界市場：動向、予測、競合分析（～2030年）

Assisted Reproductive Technology Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

生殖補助医療の世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

生殖補助医療の動向と予測

世界の生殖補助医療の市場規模は、2024～2030年にかけてCAGR 9.6%で成長し、2030年までに約462億米ドルに達すると予測されています。この市場の主な促進要因は、不妊率の上昇、生殖補助医療技術の急速な技術進歩、不妊治療に関する意識の高まりです。世界の生殖補助医療市場の将来は、不妊治療クリニック、病院、手術センター、臨床研究機関の各市場における機会によって有望視されています。

生殖補助医療市場の洞察

Lucintelの予測では、不妊率の低下、座りがちなライフスタイルの増加、妊娠遅延の傾向の増加、体外受精の低コスト化により、予測期間中、体外受精がより大きなセグメントであり続けると思われます。

この市場において、不妊治療クリニックは、生殖に関する症例の増加、不健康なライフスタイルの増加、不妊治療クリニックの増加により、最大のセグメントであり続けると思われます。

欧州は、不妊症の有病率の増加、可処分所得の増加、体外受精（IVF）に対する政府および民間組織からの資金の増加、同地域における不妊症技術の進歩により、予測期間中に最も高い成長が見込まれています。

市場規模・推計：生殖補助医療技術の市場規模を金額（10億米ドル）で推計

動向と予測分析：各セグメント・地域別の市場動向（2018～2023年）と予測（2024～2030年）

セグメンテーション分析：生殖補助医療市場を製品別、技術別、最終用途産業別、地域別など様々なセグメント別に金額（10億米ドル）で推計

地域別分析：生殖補助医療市場の北米、欧州、アジア太平洋、その他の地域内訳。

成長機会：生殖補助医療市場の製品、技術、最終用途産業、地域別の成長機会分析

戦略分析：生殖補助医療市場のM&A、新製品開発、競合情勢など

ポーターのファイブフォースモデルに基づく業界の競合強度分析

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の生殖補助医療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の生殖補助医療市場動向（2018～2023年）と予測（2024～2030年）
  • 世界の生殖補助医療市場：製品別
    • Instrument
    • Accessory & Disposable
    • Reagents & Media
  • 世界の生殖補助医療市場：技術別
    • 体外受精
    • 人工授精
    • その他
  • 世界の生殖補助医療市場：最終用途産業別
    • 不妊治療クリニック
    • 病院
    • 外科センター
    • 臨床調査
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界の生殖補助医療市場：地域別
  • 北米の生殖補助医療市場
  • 欧州の生殖補助医療市場
  • アジア太平洋の生殖補助医療市場
  • その他の地域の生殖補助医療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 製品別の世界の生殖補助医療市場の成長機会
    • 技術別の世界の生殖補助医療市場の成長機会
    • 最終用途産業別の世界の生殖補助医療市場の成長機会
    • 地域別の世界の生殖補助医療市場の成長機会
  • 世界の生殖補助医療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の生殖補助医療市場の能力拡大
    • 世界の生殖補助医療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Cosmos Biomedical
  • Microm U.K.
  • CooperSurgical
  • FUJIFILM Irvine Scientific
  • Cryolab
  • Vitrolife AB
  • European Sperm Bank
  • Bloom IVF Centre
  • Merck
  • Ferring B.V.
目次

Assisted Reproductive Technology Trends and Forecast

The future of the global assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets. The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030 with a CAGR of 9.6% from 2024 to 2030. The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.

A more than 150-page report is developed to help in your business decisions.

Assisted Reproductive Technology by Segment

The study includes a forecast for the global assisted reproductive technology by product, technology, end use industry, and region.

Assisted Reproductive Technology Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Instrument
  • Accessory & Disposable
  • Reagents & Media

Assisted Reproductive Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • In Vitro-Fertilization
  • Artificial Insemination
  • Others

Assisted Reproductive Technology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Fertility Clinic
  • Hospital
  • Surgical Center
  • Clinical Research Institute
  • Others

Assisted Reproductive Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Assisted Reproductive Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies assisted reproductive technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the assisted reproductive technology companies profiled in this report include-

  • Cosmos Biomedical
  • Microm U.K.
  • Coopersurgical
  • Fujifilm Irvine Scientific
  • Cryolab
  • Vitrolife Ab
  • European Sperm Bank
  • Bloom Ivf Centre
  • Merck
  • Ferring B.V.

Assisted Reproductive Technology Market Insights

Lucintel forecasts that in vitro-fertilization will remain the larger segment over the forecast period due to reducing fertility rate, growing sedentary lifestyle, growing trend of delayed pregnancy and low cost of IVF procedure.

Within this market, fertility clinic will remain the largest segment due to growing prevalence of reproductive cases, rising unhealthy lifestyle, and increase in the number of fertility clinics.

Europe is expected to witness highest growth over the forecast period due to growing prevalence of infertility, increasing disposable incomes, and rising funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region.

Features of the Global Assisted Reproductive Technology Market

Market Size Estimates: Assisted reproductive technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Assisted reproductive technology market by various segments, such as by product, technology, end use industry and region in terms of($B).

Regional Analysis: Assisted reproductive technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end use industries, and regions for the assisted reproductive technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the assisted reproductive technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the assisted reproductive technology market size?

Answer: The global assisted reproductive technology market is expected to reach an estimated $46.2 billion by 2030.

Q.2 What is the growth forecast for assisted reproductive technology market?

Answer: The global assisted reproductive technology market is expected to grow with a CAGR of 9.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the assisted reproductive technology market?

Answer: The major drivers for this market are rising prevalence of infertility rate, rapid technological advancements in assisted reproductive technology, and and growing awareness regarding infertility treatment.

Q4. What are the major segments for assisted reproductive technology market?

Answer: The future of the assisted reproductive technology market looks promising with opportunities in the fertility clinic, hospital, surgical center, and clinical research institute markets.

Q5. Who are the key assisted reproductive technology market companies?

Answer: Some of the key assisted reproductive technology companies are as follows:

  • Cosmos Biomedical
  • Microm U.K.
  • CooperSurgical
  • FUJIFILM Irvine Scientific
  • Cryolab
  • Vitrolife AB
  • European Sperm Bank
  • Bloom IVF Centre
  • Merck
  • Ferring B.V.

Q6. Which assisted reproductive technology market segment will be the largest in future?

Answer: Lucintel forecasts that in vitro-fertilization will remain the larger segment over the forecast period due to reducing fertility rate, growing sedentary lifestyle, growing trend of delayed pregnancy and low cost of IVF procedure.

Q7. In assisted reproductive technology market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period due to growing prevalence of infertility, increasing disposable incomes, and rising funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the assisted reproductive technology market by product (instrument, accessory & disposable, and reagents & media), technology (in vitro-fertilization, artificial insemination, and others), end use industry (fertility clinic, hospital, surgical center, clinical research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Assisted Reproductive Technology Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Assisted Reproductive Technology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Assisted Reproductive Technology Market by Product
    • 3.3.1: Instrument
    • 3.3.2: Accessory & Disposable
    • 3.3.3: Reagents & Media
  • 3.4: Global Assisted Reproductive Technology Market by Technology
    • 3.4.1: In Vitro-Fertilization
    • 3.4.2: Artificial Insemination
    • 3.4.3: Others
  • 3.5: Global Assisted Reproductive Technology Market by End Use Industry
    • 3.5.1: Fertility Clinic
    • 3.5.2: Hospital
    • 3.5.3: Surgical Center
    • 3.5.4: Clinical Research Institute
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Assisted Reproductive Technology Market by Region
  • 4.2: North American Assisted Reproductive Technology Market
    • 4.2.2: North American Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others
  • 4.3: European Assisted Reproductive Technology Market
    • 4.3.1: European Assisted Reproductive Technology Market by Technology: In Vitro-Fertilization, Artificial Insemination, and Others
    • 4.3.2: European Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others
  • 4.4: APAC Assisted Reproductive Technology Market
    • 4.4.1: APAC Assisted Reproductive Technology Market by Technology: In Vitro-Fertilization, Artificial Insemination, and Others
    • 4.4.2: APAC Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others
  • 4.5: ROW Assisted Reproductive Technology Market
    • 4.5.1: ROW Assisted Reproductive Technology Market by Technology: In Vitro-Fertilization, Artificial Insemination, and Others
    • 4.5.2: ROW Assisted Reproductive Technology Market by End Use Industry: Fertility Clinic, Hospital, Surgical Center, Clinical Research Institute, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Assisted Reproductive Technology Market by Product
    • 6.1.2: Growth Opportunities for the Global Assisted Reproductive Technology Market by Technology
    • 6.1.3: Growth Opportunities for the Global Assisted Reproductive Technology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Assisted Reproductive Technology Market by Region
  • 6.2: Emerging Trends in the Global Assisted Reproductive Technology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Assisted Reproductive Technology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Assisted Reproductive Technology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Cosmos Biomedical
  • 7.2: Microm U.K.
  • 7.3: CooperSurgical
  • 7.4: FUJIFILM Irvine Scientific
  • 7.5: Cryolab
  • 7.6: Vitrolife AB
  • 7.7: European Sperm Bank
  • 7.8: Bloom IVF Centre
  • 7.9: Merck
  • 7.10: Ferring B.V.